Mutual of America Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,628
| Closed | -$3.55M | – | 1674 |
|
|
2021
Q3 | $3.55M | Sell |
20,628
-297
| -1% | -$38.8K | 0.04% | 708 |
|
|
2021
Q2 | $2.63M | Sell |
20,925
-899
| -4% | -$113K | 0.03% | 871 |
|
|
2021
Q1 | $2.96M | Sell |
21,824
-1,210
| -5% | -$156K | 0.03% | 791 |
|
|
2020
Q4 | $2.95M | Sell |
23,034
-488
| -2% | -$57.2K | 0.03% | 747 |
|
|
2020
Q3 | $2.65M | Sell |
23,522
-21,597
| -48% | -$2.15M | 0.04% | 679 |
|
|
2020
Q2 | $4.3M | Sell |
45,119
-3,053
| -6% | -$294K | 0.06% | 424 |
|
|
2020
Q1 | $4.33M | Sell |
48,172
-10,452
| -18% | -$812K | 0.07% | 335 |
|
|
2019
Q4 | $3.11M | Sell |
58,624
-403
| -0.7% | -$18.4K | 0.04% | 703 |
|
|
2019
Q3 | $2.33M | Sell |
59,027
-328
| -0.6% | -$14.2K | 0.03% | 792 |
|
|
2019
Q2 | $2.44M | Buy |
59,355
+40
| +0.1% | +$1.66K | 0.03% | 789 |
|
|
2019
Q1 | $2.76M | Buy |
59,315
+1,073
| +2% | +$47.1K | 0.04% | 705 |
|
|
2018
Q4 | $2.54M | Hold |
58,242
| – | – | 0.04% | 679 |
|
|
2018
Q3 | $3.33M | Sell |
58,242
-428
| -0.7% | -$21K | 0.05% | 635 |
|
|
2018
Q2 | $2.85M | Sell |
58,670
-1,500
| -2% | -$54.7K | 0.04% | 722 |
|
|
2018
Q1 | $2.35M | Hold |
60,170
| – | – | 0.04% | 781 |
|
|
2017
Q4 | $2.55M | Sell |
60,170
-95
| -0.2% | -$3.56K | 0.04% | 754 |
|
|
2017
Q3 | $2.25M | Hold |
60,265
| – | – | 0.04% | 790 |
|
|
2017
Q2 | $1.83M | Sell |
60,265
-1,522
| -2% | -$44.1K | 0.03% | 859 |
|
|
2017
Q1 | $1.64M | Buy |
61,787
+17,096
| +38% | +$451K | 0.03% | 901 |
|
|
2016
Q4 | $1.14M | Buy |
44,691
+28
| +0.1% | +$887 | 0.02% | 999 |
|
|
2016
Q3 | $1.62M | Hold |
44,663
| – | – | 0.03% | 840 |
|
|
2016
Q2 | $1.52M | Buy |
44,663
+250
| +0.6% | +$8.13K | 0.03% | 827 |
|
|
2016
Q1 | $1.17M | Buy |
44,413
+50
| +0.1% | +$1.45K | 0.03% | 944 |
|
|
2015
Q4 | $2.16M | Buy |
44,363
+260
| +0.6% | +$9.36K | 0.05% | 624 |
|
|
2015
Q3 | $1.1M | Buy |
44,103
+650
| +1% | +$19.5K | 0.03% | 937 |
|
|
2015
Q2 | $1.38M | Hold |
43,453
| – | – | 0.03% | 895 |
|
|
2015
Q1 | $1.65M | Buy |
+43,453
| New | +$1.73M | 0.04% | 799 |
|
|
2014
Q4 | – | Sell |
-1,255
| Closed | -$38K | – | 1265 |
|
|
2014
Q3 | $38K | Buy |
1,255
+355
| +39% | +$10K | ﹤0.01% | 1209 |
|
|
2014
Q2 | $31K | Buy |
+900
| New | +$30.1K | ﹤0.01% | 1242 |
|
Mutual of America Capital Management's XLRN Position: Q4 2021 in Review
Mutual of America Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20,628 shares — an estimated $3.55M sold.
Mutual of America Capital Management first reported a position in XLRN in Q2 2014 and held it in 29 quarters. The position peaked at $4.33M in Q1 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Mutual of America Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Mutual of America Capital Management sold 20,628 Acceleron Pharma shares in Q4 2021, an estimated $3.55M.
- Mutual of America Capital Management first reported a position in Acceleron Pharma in Q2 2014 and held it in 29 quarters.
- Mutual of America Capital Management's Acceleron Pharma position peaked at $4.33M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Mutual of America Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.